PrimeraDx, Inc. offers multiplexed infectious disease assays. It provides Scalable Target Amplification Routine technology, which is a method for simultaneous quantitative measurement of multiple target nucleic acids. The company also offers ViraQuant, a multiplexed assay providing quantitative and simultaneous measurement of viruses; and FungiQuant Yeast and FungiQuant Mold, which are fungal panels for mycology testing. Its products are used in miRNA, DNA methylation, quantitative genotyping, gene expression, and viral load measurement applications. PrimeraDx, Inc. was founded in 2004 and is based in Mansfield, Massachusetts.
Current Team (5)Update
Past Team (3)Update
Funding Rounds (2) - $21.2MUpdate
Board Members and Advisors (5)Update
Venture capital Firm
Life sciences & healthcare
Life Sciences VC
Invus recognizes that every company is unique and that extraordinary business performance cannot...
InterWest invests an average of about $7 - 15 million over the span of their involvement with...
Healthcare Venture Capital
171 Forbes Boulavard
Mansfield, MA 02048